Immediate Impact

2 by Nobel laureates 2 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment
2024 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial
2024 Standout
1 intermediate paper

Works of D. Krasnojon being referenced

Significantly Longer Progression-Free Survival With nab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer
2009

Author Peers

Author Last Decade Papers Cites
D. Krasnojon 340 74 158 9 388
Olga Rutman 327 79 137 8 429
Jeffrey Raizer 127 153 76 12 374
J. De Waal 326 94 209 13 419
D. Mirchandani 161 125 86 15 366
L. Barreau 156 37 182 7 455
Mark Crozier 183 84 30 10 420
Shu Abe 117 56 162 8 402
Maike Sonnenberg 196 40 63 7 352
Domenico Priolo 165 58 51 9 353
Fiachra Martin 267 32 110 9 426

All Works

Loading papers...

Rankless by CCL
2026